A sterile fill finish CDMO should be judged against your product brief, not its longest equipment list. Start by asking which site and line would handle your work, what evidence supports that fit, and who owns each quality decision.
Use this guide to structure the shortlist, supplier questions and final decision memo. Bring your CMC, quality, regulatory and procurement leads into the review; commercial screening is not a substitute for their product-specific technical assessment.
What is a sterile fill-finish CDMO?
A sterile fill finish CDMO is a contract development and manufacturing organization engaged to fill and finish sterile drug products. Define the engagement precisely: which development, filling, testing and finishing tasks are included, which are excluded, and how responsibilities will be shared with your team.
What should you define before contacting suppliers?
Give every candidate the same product brief. Otherwise, you may be comparing different assumptions rather than different suppliers. Specify what you want the partner to do now and what you may need later.
Include the product presentation, proposed container, target fill volume, batch size, development stage, intended markets and timing. State any known handling or storage requirements. Mark open technical questions as questions, not settled requirements.
For the broader outsourcing model, start with what is a CDMO. Then narrow the discussion to the work package you need rather than relying on a supplier's CDMO or CMO label.
A useful brief should let a sterile fill finish CDMO respond with a proposed scope, assumptions, exclusions and evidence requests. Ask candidates to identify gaps before they quote, not after you select them.
Which capabilities deserve evidence?
Ask each sterile fill finish CDMO to connect its capabilities to your proposed work. A general capability statement is not the same as an explanation of how your product would be handled at a named site.
Questions for a comparable shortlist
| Decision area | Ask the supplier | Request for review |
|---|---|---|
| Product and presentation fit | Which parts of our proposed product brief fit your offering? | A written fit assessment with assumptions and limitations. |
| Site and line | Where would this work happen? | The proposed site, line and any unresolved equipment decisions. |
| Development support | What work is needed before the first planned batch? | A development scope with deliverables and acceptance criteria. |
| Testing and finishing | What is included, subcontracted or excluded? | A responsibility map covering testing, inspection, packaging and storage. |
| Scale and continuity | How would the plan change if demand changes? | Options, constraints and the work needed for any proposed transition. |
Keep marketing descriptions separate from technical evidence. Have your specialists decide whether the materials supplied are relevant to the actual product, proposed process and intended markets.
How should quality and risk be reviewed?
Evaluate a sterile fill finish CDMO with your quality team before treating it as a commercial finalist. Ask that team to define the document review, site assessment and unresolved questions needed for a selection decision.
Request an explanation of the proposed contamination-control approach, process qualification, container-closure assessment and handling of deviations. Do not prescribe technical methods from a buyer guide; ask qualified specialists to judge the supplier's approach against your product requirements.
Make ownership explicit. Who investigates a problem? Who receives notice of a proposed change? Who reviews records, answers regulatory questions and makes each disposition decision? Put the answers into the proposed quality agreement and operating responsibilities.
Also ask about subcontracted work, record access and escalation contacts. A statement that the supplier handles quality should lead to a responsibility map, not end the conversation.
How does selection work in practice?
Use a staged review so the sterile fill finish CDMO selection does not become a contest between sales presentations. Advance candidates only when the next decision has enough evidence behind it.
- Screen for fit. Share the product brief and ask candidates to identify mismatches, missing information and proposed scope.
- Compare written responses. Separate confirmed scope from assumptions, optional work and unresolved technical questions.
- Run specialist due diligence. Let quality, regulatory and technical leads set their review requirements and record their findings.
- Align commitments. Reconcile the proposal, quality responsibilities, schedule and commercial terms before signing.
- Plan the handoff. Name the people, documents and acceptance criteria needed to start the engagement.
Treat this as a suggested buying sequence, not a manufacturing protocol. Adjust it to your organization's governance and the product's development stage.
How should you compare costs and schedules?
Compare each sterile fill finish CDMO on the same scope and assumptions. Ask for a breakdown of development work, setup, materials, manufacturing, testing, finishing, storage and any third-party charges relevant to the proposal.
Request a written account of expected material use and proposed loss allowances. Ask how the supplier would report filled, rejected and accepted units, and which quantities underpin the quote. Avoid comparing a batch price with a per-unit price without reconciling their denominators.
For timing, distinguish a proposed date from a reserved commitment. Ask what must happen before work starts, what could move the schedule and who bears each dependency. Record the effect of changes, cancellations and rescheduling in the commercial review.
There is no universal budget or lead time offered here. Use product-specific proposals rather than a generic price range.
Which mistakes should buyers avoid?
Do not choose a sterile fill finish CDMO because its brochure uses the right vocabulary. Test the proposed engagement. Watch for these decision errors:
- Comparing unequal scopes: reconcile inclusions and exclusions before comparing prices.
- Leaving responsibilities implied: name an owner for each handoff and decision.
- Treating capacity as a promise: document the conditions behind the proposed slot.
- Assuming future scale: request a written transition option and its dependencies.
- Closing the shortlist too early: keep unresolved specialist findings visible in the decision memo.
Do not let a strong score in one area cancel an unmet essential requirement. Set those requirements before evaluating candidates.
How should success be measured?
Agree on measures before onboarding the sterile fill finish CDMO. Separate project progress from supply performance, and define each measure well enough that both teams calculate it the same way.
Suggested engagement measures
| Measure | Define before work starts |
|---|---|
| Milestone delivery | The deliverable, due date and evidence required for acceptance. |
| Material accountability | How received, used, returned and lost quantities will be reconciled. |
| Accepted output | The agreed quantity categories and reporting denominator. |
| Issue resolution | Notification timing, escalation ownership and closure evidence. |
| Cost control | The baseline scope and authorization process for additional charges. |
Review trends alongside the underlying records and explanations. Treat these as management measures, not proof that a batch is suitable for release. Keep technical acceptance and release decisions with the designated qualified owners.
What should be in the final decision memo?
Write a short recommendation that another leader can challenge. Name the proposed partner, site and work package. Explain why the fit is acceptable and list the evidence your specialists used to reach that judgment.
Include the remaining conditions, scope exclusions, schedule dependencies, quality responsibilities and commercial exposure. Give each unresolved item an owner and a decision date. Make clear which items must close before a contract or work starts.
Choose the sterile fill finish CDMO whose proposed engagement your team can explain and govern—not merely the candidate with the most persuasive presentation. The final recommendation should connect requirements, evidence and commitments in one place.
About Bob Generale
Bob Generale is President of Percepture. This guide focuses on the business questions behind supplier selection and the evidence buyers should request.
